ING Groep »

Royalty Pharma shares owned by ING Groep

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by ING Groep from 13F filings

Historical chart of ING Groep investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by ING Groep consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by ING Groep

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 37k 30.37
2023-12-31 $1.3M 46k 28.09

More positions owned by ING Groep

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Mastercard Incorporated Cl A (MA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Qualcomm (QCOM)
Alphabet Cap Stk Cl C (GOOG)
Adobe Systems Incorporated (ADBE)
Cedar Fair Depositry Unit (FUN)
salesforce (CRM)
Sherwin-Williams Company (SHW)
Micron Technology (MU)

View all positions for ING Groep

Top funds holding Royalty Pharma

Vanguard Group
Baillie Gifford & Co
Viking Global Investors
Jpmorgan Chase & Co
Unisphere Establishment
Norges Bank Investment Management
Amundi
Siguler Guff Advisers
Legal & General Group
Goldman Sachs Group
Man Group
CalPERS
Two Sigma Investments
Two Sigma Advisers
Henderson Group

View all funds holding Royalty Pharma